Stoke Therapeutics, Inc. (STOK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Stoke Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -273.00x | -6.69x | -2.21x | -3.55x | -10.27x | -39.70x |
| P/B Ratio | 5.33x | 2.60x | 1.45x | 1.94x | 4.05x | 7.25x |
| P/S Ratio | 10.19x | 16.30x | 26.36x | 28.94x | 0.00x | 0.00x |
| Profitability | ||||||
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 0.0% | 0.0% |
| Operating Margin | -11.2% | -277.3% | -1307.2% | -841.2% | 0.0% | 0.0% |
| Net Margin | -3.7% | -243.4% | -1192.5% | -814.7% | 0.0% | 0.0% |
| EBITDA Margin | -10.2% | -271.4% | -1279.1% | -828.8% | 0.0% | 0.0% |
| Liquidity | ||||||
| Current Ratio | 5.28x | 5.81x | 6.99x | 7.77x | 13.37x | 25.73x |
| Quick Ratio | 5.28x | 5.81x | 6.99x | 7.77x | 13.37x | 25.73x |
| Leverage | ||||||
| Debt/Equity | 0.00x | 0.01x | 0.01x | 0.01x | 0.01x | 0.00x |
YoY = year-over-year change. Source: FMP..